No connection

Search Results

Earnings Score 35 Bearish

Nurix Therapeutics Reports Widening Q1 Loss Amid Sanofi Revenue Decline

Apr 08, 2026 10:57 UTC
NRIX
Short term

Nurix Therapeutics saw its quarterly net loss expand to $87.2 million as revenue from its partnership with Sanofi dipped. The company maintains a strong cash position despite the quarterly downturn.

  • Q1 net loss of $87.2 million vs $56.4 million YoY
  • Revenue fell to $6.3 million from $18.5 million
  • Revenue decline linked to ending research terms with Sanofi
  • Cash and marketable securities total $540.7 million
  • Shares declined 3.06% in pre-market trading

Nurix Therapeutics (NRIX) reported a significant increase in net losses for the first quarter of 2026, reflecting higher operational costs and a decline in partnership revenue. The company's net loss reached $87.2 million, or $0.79 per share, a marked increase from the $56.4 million loss, or $0.67 per share, recorded during the same period last year. Revenue for the quarter plummeted to $6.3 million, down from $18.5 million in the prior year. According to the company, this decline was primarily driven by a decrease in revenue from its collaboration with Sanofi, as the initial research terms for certain drug targets reached their conclusion. Despite the widening losses and revenue contraction, Nurix remains well-capitalized to fund its ongoing operations. As of February 28, 2026, the firm reported that its cash, cash equivalents, and marketable securities totaled $540.7 million. Investors reacted negatively to the financial results in early trading. Shares of Nurix were down 3.06 percent to $15.85 in pre-market trading on the Nasdaq, as the market digested the impact of the reduced partnership income.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Related Articles

Score 52 Bullish

Bank of America Outperforms Q1 Expectations with Strong Loan Growth

Apr 17, 23:40

Score 48 Bullish

Autoliv Shares Surge Following Q1 Earnings Beat

Apr 17, 23:09

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile